Novartis Investigative Site

Lynbrook, New York 11563

0 studies enrolling now · 2 studies all time

What they study most

Choroidal Neovascularization, Glaucoma, Macular Degeneration, Ocular Hypertension

Studies at this site

• Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension — Completed
• Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization — Completed